» Articles » PMID: 30093397

The Homeobox Transcription Factor HB9 Induces Senescence and Blocks Differentiation in Hematopoietic Stem and Progenitor Cells

Overview
Journal Haematologica
Specialty Hematology
Date 2018 Aug 11
PMID 30093397
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The homeobox gene encodes for the transcription factor HB9, which is essential for pancreatic as well as motor neuronal development. Beside its physiological expression pattern, aberrant HB9 expression has been observed in several neoplasias. Especially in infant translocation t(7;12) acute myeloid leukemia, aberrant HB9 expression is the only known molecular hallmark and is assumed to be a key factor in leukemic transformation. However, so far, only poor functional data exist addressing the oncogenic potential of HB9 or its influence on hematopoiesis. We investigated the influence of HB9 on cell proliferation and cell cycle , as well as on hematopoietic stem cell differentiation using murine and human model systems. , HB9 expression led to premature senescence in human HT1080 and murine NIH3T3 cells, providing for the first time evidence for an oncogenic potential of HB9. Onset of senescence was characterized by induction of the p53-p21 tumor suppressor network, resulting in growth arrest, accompanied by morphological transformation and expression of senescence-associated β-galactosidase. , HB9-transduced primary murine hematopoietic stem and progenitor cells underwent a profound differentiation arrest and accumulated at the megakaryocyte/erythrocyte progenitor stage. In line, gene expression analyses revealed expression of erythropoiesis-related genes in human CD34hematopoietic stem and progenitor cells upon HB9 expression. In summary, the novel findings of HB9-dependent premature senescence and myeloid-biased perturbed hematopoietic differentiation, for the first time shed light on the oncogenic properties of HB9 in translocation t(7;12) acute myeloid leukemia.

Citing Articles

The whole chromosome-level genome provides resources and insights into the endangered fish Percocypris pingi evolution and conservation.

He Z, Li C, Gao K, Zheng X, Wang X, Wang H BMC Genomics. 2024; 25(1):1175.

PMID: 39627733 PMC: 11616138. DOI: 10.1186/s12864-024-11100-9.


Altered enhancer-promoter interaction leads to MNX1 expression in pediatric acute myeloid leukemia with t(7;12)(q36;p13).

Weichenhan D, Riedel A, Sollier E, Toprak U, Hey J, Breuer K Blood Adv. 2024; 8(19):5100-5111.

PMID: 39121370 PMC: 11460460. DOI: 10.1182/bloodadvances.2023012161.


Backtracking NOM1::ETV6 fusion to neonatal pathogenesis of t(7;12) (q36;p13) infant AML.

Bousquets-Munoz P, Molina O, Varela I, Alvarez-Eguiluz A, Fernandez-Mateos J, Gomez A Leukemia. 2024; 38(8):1808-1812.

PMID: 38806630 PMC: 11286527. DOI: 10.1038/s41375-024-02293-9.


First mouse model of infant acute myeloid leukemia with t(7;12)(q36;p17).

Jevtic Z, Schwaller J Haematologica. 2023; 109(3):712-714.

PMID: 37584296 PMC: 10905090. DOI: 10.3324/haematol.2023.283659.


Aberrant MNX1 expression associated with t(7;12)(q36;p13) pediatric acute myeloid leukemia induces the disease through altering histone methylation.

Waraky A, Ostlund A, Nilsson T, Weichenhan D, Lutsik P, Bahr M Haematologica. 2023; 109(3):725-739.

PMID: 37317878 PMC: 10905087. DOI: 10.3324/haematol.2022.282255.


References
1.
Baldwin E, Osheroff N . Etoposide, topoisomerase II and cancer. Curr Med Chem Anticancer Agents. 2005; 5(4):363-72. DOI: 10.2174/1568011054222364. View

2.
Deguchi Y, Kehrl J . Selective expression of two homeobox genes in CD34-positive cells from human bone marrow. Blood. 1991; 78(2):323-8. View

3.
Rodier F, Campisi J . Four faces of cellular senescence. J Cell Biol. 2011; 192(4):547-56. PMC: 3044123. DOI: 10.1083/jcb.201009094. View

4.
Harrison K, Druey K, Deguchi Y, Tuscano J, Kehrl J . A novel human homeobox gene distantly related to proboscipedia is expressed in lymphoid and pancreatic tissues. J Biol Chem. 1994; 269(31):19968-75. View

5.
Wildenhain S, Ruckert C, Rottgers S, Harbott J, Ludwig W, Schuster F . Expression of cell-cell interacting genes distinguishes HLXB9/TEL from MLL-positive childhood acute myeloid leukemia. Leukemia. 2010; 24(9):1657-60. DOI: 10.1038/leu.2010.146. View